Autor: |
Kanazawa S; Dept. of Surgery, Division of General and Gastroenterological Surgery, Toho University School of Medicine., Seo A, Tokura N, Honda R, Kase H, Teramoto T |
Jazyk: |
japonština |
Zdroj: |
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2006 Jan; Vol. 33 (1), pp. 113-7. |
DOI: |
10.2217/14750708.3.1.113 |
Abstrakt: |
A 64-year-old man with unresectable sigmoid adenocarcinoma due to peritoneal dissemination (P3) and liver metastasis (H2) treated with TS-1, showed a complete response. TS-1 is an oral anticancer drug that produces biochemical modulation. It is composed of tegafur, gimestat and ostat potassium in a molar ratio of 1:0.4:1 to increase the effect of 5-FU and to decrease toxicity in the digestive canal. Treatment with TS-1 requires no hospitalization and can enhance the quality of life of the patient. TS-1 is expected to be an effective agent for the treatment of colon cancer with liver metastasis and peritoneal dissemination. |
Databáze: |
MEDLINE |
Externí odkaz: |
|